A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3.
about
Clinical Pharmacology and Translational Aspects of Bispecific AntibodiesCharacterization of the first-in-class T-cell-engaging bispecific single-chain antibody for targeted immunotherapy of solid tumors expressing the oncofetal protein claudin 6Immune-mediated liver injury of the cancer therapeutic antibody catumaxomab targeting EpCAM, CD3 and Fcγ receptors.Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy.Recent advances of bispecific antibodies in solid tumors.In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy.T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics.Bispecific antibodies: design, therapy, perspectives.Bispecific antibodies in cancer immunotherapy.Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis
P2860
Q33648086-F41079A0-16AF-4846-AC03-520ADA027F0FQ36821083-32E5E2FA-AA41-4563-9FAC-2BC582743B8CQ37317487-88E629EA-653B-4982-A290-D2F06449DD79Q38756773-96135995-D224-4494-9CAD-3F06E3E47C84Q41696278-24BB359D-AC71-4311-9699-100498273A05Q41919495-32D14F21-CAFA-448A-B254-E233AD1816D6Q47570404-43F2B4E2-C554-4E3C-8DA9-BD7049FC3609Q49195146-D5DBBA4F-C52C-4E67-AF02-750F26848313Q51309023-AC10441F-3FA3-41C3-A476-C900897DF966Q58788761-53D5AE9F-4338-4F76-8A7A-304A01DC5E71
P2860
A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
A phase I trial of intravenous ...... and the T cell coreceptor CD3.
@en
A phase I trial of intravenous ...... and the T cell coreceptor CD3.
@nl
type
label
A phase I trial of intravenous ...... and the T cell coreceptor CD3.
@en
A phase I trial of intravenous ...... and the T cell coreceptor CD3.
@nl
prefLabel
A phase I trial of intravenous ...... and the T cell coreceptor CD3.
@en
A phase I trial of intravenous ...... and the T cell coreceptor CD3.
@nl
P2093
P2860
P50
P1476
A phase I trial of intravenous ...... and the T cell coreceptor CD3.
@en
P2093
Christian Dittrich
Holger Martinius
Rodrigo Dienstmann
Wilfried Büchler
P2860
P2888
P304
P356
10.1007/S00280-015-2728-5
P577
2015-03-27T00:00:00Z